Printer Friendly

TURNER RESIGNS AS PRESIDENT AND CEO OF PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA INC.; RECOMMENDS MAJEK AS SUCCESSOR

 SOUTH PLAINFIELD, N.J., April 23 /PRNewswire/ -- Princeton Diagnostic Laboratories of America Inc. (AMEX: PDA) announced today that at a March 1993 board of directors meeting, Dr. Carlton E. Turner resigned from his positions as president and chief executive officer effective May 1, 1993. Dr. Turner will remain a director of the company and continue to provide clinical and toxicological consulting services to the company and its clients.
 Dr. Turner recommended to the board the election of the current vice president of operations and finance, Warren N. Majek, to the posts of president and chief executive officer. The board voted unanimously to elect Mr. Majek, effective May 1, 1993. Mr. Majek is a graduate of Michigan State University and the Johnson Graduate School of Business at Cornell University. Prior to joining PDLA, Mr. Majek was director of corporate planning at MetPath Inc., a Corning subsidiary, and was a founding officer of Lifepoint Medical Corporation. Mr. Majek stated his confidence in "implementing the plan prepared by Dr. Turner and approved by the board to return PDLA to growth and profitability."
 PDLA processes toxicology samples under federal guidelines, for pre-employment and random sampling drug-free workplace programs. These tests are used by major corporations, associations and operating companies, and includes 12 percent of the top 50 industrial companies of the Fortune 500, for diagnostic pre-employment screening. In addition, PLDA provides specialized clinical testing relating to the detection and monitoring of the treatment of psychiatric disorders, drug abuse, and other illnesses for private psychiatric hospitals, psychiatrists and other clinical laboratories.
 -0- 4/23/93
 /CONTACT: Warren N. Majek, VP-operations and finance of PDLA, 800-237-7352/
 (PDA)


CO: Princeton Diagnostic Laboratories of America Inc. ST: New Jersey IN: MTC SU: PER

GK-TS -- NY071 -- 0123 04/23/93 13:52 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 23, 1993
Words:294
Previous Article:NALCO REPORTS SOLID FIRST QUARTER SALES AND EARNINGS AND A 7 PERCENT DIVIDEND INCREASE
Next Article:FIRST CASH, INC. REGISTERS WITH SEC
Topics:


Related Articles
NIDA CERTIFIES PRECISION DRUG-TESTING LABORATORY OF AMERICA
WARREN N. MAJEK JOINS PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA AS GENERAL MANAGER SECRETARY/TREASURER
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA REORGANIZES ITS SUBSIDIARY
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC. MARKETS DRUG TESTING PROGRAM
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC. APPOINTS MCBEE VP
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA ANNOUNCES SALE OF FACILITY
EDITEK, INC. ANNOUNCES INTENT TO ACQUIRE PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC.
PRINCETON DIAGNOSTIC LABORATORIES OF AMERICA, INC. SHAREHOLDERS APPROVE MERGER WITH EDITEK, INC.
MICHAEL TERRETTI JOINS PDLA, INC. AS VICE PRESIDENT AND GENERAL MANAGER
EDITEK, INC. ENGAGES INVESTMENT BANKER FOR ITS ACQUISITIONS PROGRAM

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters